Parameters | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
Odds ratio (95% CI) | P-value | Odds ratio (95% CI) | P-value | |
Age (>  60 years) | 0.63 (0.16–2.41) | 0.50 |  |  |
Sex (Female) | 0.70 (0.16–2.98) | 0.63 |  |  |
Staging of hepatic fibrosis (Stage 4) | 1.44 (0.38–5.57) | 0.59 |  |  |
AFP (>  8.7 ng/ml) | 2.67 (0.65–10.88) | 0.17 |  |  |
PIVKA-II (>  40 mAU/mL) | 4.38 (1.03–18.63) | 0.05 | 2.71 (0.47–15.58) | 0.26 |
Edmondson-Steiner grade of HCC (III) | 4.75 (0.95–23.85) | 0.06 | 5.64 (0.67–47.25) | 0.11 |
Total volume of HCC (>  4.5 ml) | 2.16 (0.54–8.57) | 0.27 |  |  |
Maximal diameter of HCC (>  32 mm) | 4.53 (1.06–19.41) | 0.04 | 4.04 (0.67–24.37) | 0.13 |
Peritumoral enhancement | 3.15 (0.78–12.73) | 0.11 |  |  |
Nonsmooth tumor margin | 3.00 (0.72–12.55) | 0.13 |  |  |
NIC of outer layer 1 (> 0.082 mg/ml) | 6.42 (1.37–30.05) | 0.02 | 7.14 (1.12–45.40) | 0.04 |